ACPL is India's premier regulatory affairs consultancy — guiding pharmaceutical, medical device, food, and cosmetic companies through CDSCO, FSSAI, BIS, and 15+ regulatory frameworks. From first filing to market launch.
From pharmaceuticals to food products, we provide end-to-end regulatory support across every major product category in India.
CDSCO registration, import licenses, and market authorization for Class A–D devices.
Drug registration, manufacturing licenses, clinical trial approvals through CDSCO.
IVD product registration and compliance under India's evolving IVDR framework.
Regulatory pathways for vaccines, blood products, and biosimilars.
CDSCO cosmetic registration, import licenses, and cosmetovigilance compliance.
FSSAI licensing, food safety compliance, labeling regulations, and import clearance.
Registration of insecticides, pesticides, and home care products under CIB&RC.
BIS certification, Legal Metrology compliance, and EPR registration for consumer products.
Trusted by 1,150+ Clients Worldwide
Three pillars of expertise that cover the full lifecycle of regulatory compliance in India.
End-to-end regulatory support across 15+ Indian regulatory bodies including CDSCO, FSSAI, BIS, DGFT, WPC, and more. We handle product registration, manufacturing licenses, import permits, and ongoing compliance — so you can focus on your business.
Comprehensive post-market surveillance and safety monitoring services. Our vigilance teams ensure your products maintain compliance throughout their lifecycle — covering drugs, devices, cosmetics, and food products.
From protocol development to ICMR/DCGI approvals, we manage the full clinical trial lifecycle in India. Our team navigates the regulatory requirements so your studies run on time and within compliance.
Accredited Consultants Pvt. Ltd. (ACPL), the flagship company of the ACPL Group, is one of India's leading regulatory affairs consultancies. With over 25 years of experience and a team of 18+ domain experts, we've helped more than 1,150 clients bring safe, compliant products to market.
Recognised among the Top 10 Most Promising Medical Device and Pharmaceutical Regulatory Consultants in Asia 2023 by Asia Business Outlook Magazine, ACPL combines deep regulatory knowledge with a client-first approach that delivers results.
Medical Device & Pharmaceutical Regulatory Consultants — Asia Business Outlook Magazine, 2023
Whether you're launching a new product or expanding into India, our team of 18+ regulatory experts is ready to guide you every step of the way.
Asia Business Outlook Magazine
ACPL was recognized among the top regulatory consultancies across the Asia-Pacific region for its deep domain expertise, client-first approach, and consistent track record across pharmaceuticals, medical devices, and allied healthcare sectors.
Stay current with regulatory updates, compliance insights, and industry developments.
PESO, or the Petroleum and Explosives Safety Organisation, stands as India’s central authority for keeping hazardous substances in check. They’re…
Read MoreCPCB has moved from rule-making to enforcement on plastic EPR—Registered Environment Auditors, customs blocks, and crore-level penalties are now live.…
Read MoreRegulatory compliance has always been the backbone of a trustworthy supply chain, but a recent directive from the Central Drugs…
Read More
